Skip to content

ANALYTIKK

Active
Private limited companyfounded 2020active for 6 yearsBlauwe gaanweg 36, 9150 Beveren-Kruibeke-Zwijndrecht, BelgiumKBO/BCE: BE 0755.963.461

From the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

ANALYTIKK has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,000 and a net result of €130,801. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 09-10-2020 Normal situation
Legal form
Private limited company
Registered office
Blauwe gaanweg 36, 9150 Beveren-Kruibeke-Zwijndrecht
Activity
Medical imaging and medical laboratories NACE 86910and 4 others
Establishment unit
2.308.248.523 9150 Beveren-Kruibeke-Zwijndrecht, since 09-10-2020
Financial year end
31 December
Peppol
Reachable

Who decides

Board
  • Kehoe KaatDirector · since 09-10-2020

How it is doing

90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€206,449
▲ 10.4%
Turnover
≈ €410,000
estimated
Profit
€130,801
▲ 5.1%
Equity
€3,000
▼ 97.6%
Total assets
€524,362
▲ 4.9%
2025 accounts 50 days early
Filed on 11-06-2026at the National Bank
Why 90raises riskEquity €3,000 (0.6% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €524,362Figures for financial year 2025 (filed 11-06-2026)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 18% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 26-24
equity 0.6% of total assets
Liquidity 28-21
short-term debt 50.6% · cash 2.5%
Profitability 100=
return on assets 24.9%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025highest value 12-2025: < 0.1%▼ -0.2 percentage points vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 5% on solvency, 5% on liquidity, 60% on profitability and 3% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €524,362
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 11-06-2026)
NBB · annual accounts
raises risk · Equity €3,000 (0.6% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
50 days early
2024
38 days early
2023
171 days early
2022
25 days late
2021
5 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 48 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 June (4 of the last 5 filed years within 63 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Financials · financial year 2025, micro format

Latest annual accounts filed

Annual accounts 2025

View at the NBB
Financial year ended
31-12-2025
Filed on
11-06-2026
Format
micro format
Reference
2026-00157724
Turnover
≈ €410,000
Estimated: probably between €310,000 and €510,000
Total assets
€524,362▲ 4.9%
2024 · €500,057
Net result
€130,801▲ 5.1%
2024 · €124,403
Working capital
-€158,570▼ 2,511%
2024 · -€6,073
Trend over the years

2021 to 2025, 5 financial years

After the dip in 2023 the operating result has climbed two years in a row; 2025 is 6% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€176,552 2025 Net result€130,801 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20212022202320242025
Operating result€149,143-€162,401▲ 8.9%€158,198▼ 2.6%€166,212▲ 5.1%€176,552▲ 6.2%
Net result€114,528within the sector's middle half-€120,869above the sector's middle half▲ 5.5%€118,335above the sector's middle half▼ 2.1%€124,403above the sector's middle half▲ 5.1%€130,801above the sector's middle half▲ 5.1%
Equity€117,528below the sector's middle half-€238,396within the sector's middle half▲ 103%€238,396within the sector's middle half=€127,403within the sector's middle half▼ 46.6%€3,000below the sector's middle half▼ 97.6%
Total assets€250,477below the sector's middle half-€517,559within the sector's middle half▲ 107%€742,099above the sector's middle half▲ 43.4%€500,057within the sector's middle half▼ 32.6%€524,362within the sector's middle half▲ 4.9%
Debt€132,949-€279,163▲ 110%€503,703▲ 80.4%€372,654▼ 26.0%€521,362▲ 39.9%
Working capital€100,447within the sector's middle half-€218,026within the sector's middle half▲ 117%€142,959within the sector's middle half▼ 34.4%-€6,073below the sector's middle half-€158,570below the sector's middle half▼ 2,511%
Solvency46.9%within the sector's middle half-46.1%within the sector's middle half▼ 0.9pp32.1%below the sector's middle half▼ 13.9pp25.5%below the sector's middle half▼ 6.6pp0.6%below the sector's middle half▼ 24.9pp
Current ratio3.61within the sector's middle half-3.89within the sector's middle half▲ 0.281.66within the sector's middle half▼ 2.230.94below the sector's middle half▼ 0.720.40below the sector's middle half▼ 0.54
Return on assets (ROA)45.7%above the sector's middle half-23.4%within the sector's middle half▼ 22.4pp15.9%within the sector's middle half▼ 7.4pp24.9%within the sector's middle half▲ 8.9pp24.9%within the sector's middle half▲ 0.1pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €524,362
Fixed assets €417,431 ▲ 2.7%
Current assets €106,931 ▲ 14.0%
Equity and liabilities €524,362
Equity €3,000 ▼ 97.6%
Debt €521,362 ▲ 39.9%
Debt's share of the balance-sheet total rises from 74.5% to 99.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€195,194▲
2024 · €184,168
Cash flow
€149,443▲
2024 · €142,359
Interest coverage
31.90▲
2024 · 31.43
Debt ≤ 1 year
€265,501▲
2024 · €99,836
Debt > 1 year
€255,860▼
2024 · €272,818
Income taxes
€39,853▲
2024 · €36,991
A ratio outside any meaningful range has been withheld (balance sheet total €524,362, equity €3,000).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 875 companies that looked in July 2024 the way this one looks now, 1.4% went bankrupt within 24 months and 96.6% are still going.

  • Small
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
1.4% went bankrupt
1.9% stopped otherwise
96.6% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 875 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines

Source: Annual accounts 2025 at the NBB, filed with the National Bank on 11-06-2026.

Balance sheet Code20242025
Assets
Total assets20/58€500,057€524,362▲
Fixed assets21/28€406,295€417,431▲
Tangible fixed assets22/27€406,295€417,431▲
Land and buildings22€396,780€410,643▲
Plant, machinery and equipment23€2,387€3,118▲
Furniture and vehicles24€6,780€3,605▼
Other tangible fixed assets26€347€65▼
Current assets29/58€93,762€106,931▲
Amounts receivable within one year40/41€47,172€30,602▼
Trade receivables40€46,120€30,602▼
Other amounts receivable41€1,052-
Current investments50/53€25,045€63,265▲
Cash at bank and in hand54/58€21,545€13,064▼
Equity and liabilities
Total equity and liabilities10/49€500,057€524,362▲
Equity10/15€127,403€3,000▼
Contributions10/11€3,000€3,000=
Reserves13€124,403-
Distributable reserves133€124,403-
Amounts payable17/49€372,654€521,362▲
Amounts payable after more than one year17€272,818€255,860▼
Financial debts170/4€272,818€255,860▼
Amounts payable within one year42/48€99,836€265,501▲
Current portion of amounts payable after more than one year42€16,957€28,746▲
Trade debts44€3,433€6,910▲
Suppliers440/4€3,433€6,910▲
Taxes, remuneration and social security45€42,408€15,608▼
Taxes450/3€36,408€12,608▼
Remuneration and social security454/9€6,000€3,000▼
Other amounts payable47/48€37,037€214,238▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17,956€18,642▲
Other operating charges640/8€2,849€11,255▲
Gross operating margin9900€187,017€206,449▲
Operating profit (loss)9901€166,212€176,552▲
Financial income75/76B€1,042€220▼
Recurring financial income75€1,042€220▼
Financial charges65/66B€5,860€6,118▲
Recurring financial charges65€5,860€6,118▲
Profit (loss) for the period before taxes9903€161,395€170,654▲
Income taxes67/77€36,991€39,853▲
Profit (loss) for the period9904€124,403€130,801▲
Profit (loss) for the period to be appropriated9905€124,403€130,801▲
Appropriation of the result
Profit (loss) to be appropriated9906€124,403€130,801▲
Transfer from equity791/2€353,731€124,403▼
Transfer to equity691/2€124,403-
To other reserves6921€124,403-
Profit to be distributed694/7€353,731€255,204▼
Return on contributions (dividend)694€353,731€255,204▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are in the accounts filed with the National Bank.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,153€10,674€13,202€17,956€18,642▲ 3.8%
Other operating charges640/8€13,228€1,552€399€2,849€11,255▲ 295%
Gross operating margin9900€166,524€174,627€171,799€187,017€206,449▲ 10.4%
Operating profit (loss)9901€149,143€162,401€158,198€166,212€176,552▲ 6.2%
Financial income75/76B€0€4€777€1,042€220▼ 78.9%
Recurring financial income75€0€4€777€1,042€220▼ 78.9%
Financial charges65/66B€1,695€5,878€6,224€5,860€6,118▲ 4.4%
Recurring financial charges65€1,695€5,878€6,224€5,860€6,118▲ 4.4%
Profit (loss) for the period before taxes9903€147,448€156,527€152,752€161,395€170,654▲ 5.7%
Income taxes67/77€32,921€35,659€34,417€36,991€39,853▲ 7.7%
Profit (loss) for the period9904€114,528€120,869€118,335€124,403€130,801▲ 5.1%
Profit (loss) for the period to be appropriated9905€114,528€120,869€118,335€124,403€130,801▲ 5.1%
Line20212022202320242025Change
Assets
Total assets20/58€250,477€517,559€742,099€500,057€524,362▲ 4.9%
Fixed assets21/28€111,485€224,001€383,019€406,295€417,431▲ 2.7%
Tangible fixed assets22/27€111,485€224,001€383,019€406,295€417,431▲ 2.7%
Land and buildings22€105,760€214,219€376,476€396,780€410,643▲ 3.5%
Plant, machinery and equipment23---€2,387€3,118▲ 30.6%
Furniture and vehicles24€4,531€8,870€5,913€6,780€3,605▼ 46.8%
Other tangible fixed assets26€1,194€912€630€347€65▼ 81.3%
Current assets29/58€138,991€293,558€359,080€93,762€106,931▲ 14.0%
Amounts receivable within one year40/41€12,650€20,332€27,907€47,172€30,602▼ 35.1%
Trade receivables40€12,650€20,332€27,907€46,120€30,602▼ 33.6%
Other amounts receivable41---€1,052--
Current investments50/53--€110,005€25,045€63,265▲ 153%
Cash at bank and in hand54/58€125,553€273,226€218,842€21,545€13,064▼ 39.4%
Deferred charges and accrued income490/1€789-€2,326---
Equity and liabilities
Total equity and liabilities10/49€250,477€517,559€742,099€500,057€524,362▲ 4.9%
Equity10/15€117,528€238,396€238,396€127,403€3,000▼ 97.6%
Contributions10/11€3,000€3,000€3,000€3,000€3,000=
Reserves13€114,528€235,396€235,396€124,403--
Distributable reserves133€114,528€235,396€235,396€124,403--
Amounts payable17/49€132,949€279,163€503,703€372,654€521,362▲ 39.9%
Amounts payable after more than one year17€94,405€203,631€287,582€272,818€255,860▼ 6.2%
Financial debts170/4€94,405€203,631€287,582€272,818€255,860▼ 6.2%
Amounts payable within one year42/48€38,544€75,532€216,121€99,836€265,501▲ 166%
Current portion of amounts payable after more than one year42€5,057€5,057€16,957€16,957€28,746▲ 69.5%
Trade debts44-€1,364€18,843€3,433€6,910▲ 101%
Suppliers440/4-€1,364€18,843€3,433€6,910▲ 101%
Taxes, remuneration and social security45€32,921€68,579€49,946€42,408€15,608▼ 63.2%
Taxes450/3€32,921€68,579€46,946€36,408€12,608▼ 65.4%
Remuneration and social security454/9--€3,000€6,000€3,000▼ 50.0%
Other amounts payable47/48€566€532€130,375€37,037€214,238▲ 478%
Line20212022202320242025Change
Profit (loss) for the period9904€114,528€120,869€118,335€124,403€130,801▲ 5.1%
+ Depreciation and write-downs630€4,153€10,674€13,202€17,956€18,642▲ 3.8%
Operating cash flow (approximation)€118,681€131,543€131,537€142,359€149,443▲ 5.0%
Investment in fixed assets (approximation)--€123,190-€172,220-€41,232-€29,778▲ 27.8%
Change in cash-€147,673-€54,384-€197,297-€8,481▲ 95.7%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (5)
Financial year Type Filed Reference Document
31-12-2025 micro format 11-06-2026 2026-00157724 NBB
31-12-2024 micro format 23-06-2025 2025-00170973 PDF
31-12-2023 micro format 11-02-2024 2024-00029476 PDF
31-12-2022 micro format 25-08-2023 2023-00376336 PDF
31-12-2021 abbreviated format 26-07-2022 2022-20231990 PDF

Similar companies · same sector, comparable size

Of the 696 active companies whose main activity is medical imaging and medical laboratories (NACE 86910), figures are known for 528. 59 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2025 · 1 entry · €1,785 awarded · €1,680 paid
Schemes
1 entry · €1,785 · €1,680 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director
Kehoe Kaat
Director · since 09-10-2020 · in the 2025 annual accounts, filed on 11-06-2026
Current

Mandate history

1 person, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
Kehoe Kaat
  • Director, from 09-10-2020 to date
See the board, name and registered office on a given date →

Owners and capital

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 9 October 2020, ANALYTIKK was incorporated as a private limited company.1 In 2023 the registered office moved to Kruibeke.2 Total assets went from €250,477 in 2021 to €524,362 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-11-2023
  3. 3National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
11-06
NBB filing Annual accounts filedNBB
financial year 2025 · micro format
2025
31-12
Financial Highest result from 2021 to 2025net €130,801 ▲5.1%
Operating result €176,552, net result €130,801, both a record.
23-06
NBB filing Annual accounts filedPDF
financial year 2024 · micro format
2024
11-02
NBB filing Annual accounts filedPDF
financial year 2023 · micro format
2023
22-11
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 10-10-2023
  • Registered-office move, Blauwe Gaanweg 36 te 9150 Kruibeke

Open the act in the Belgian Official Gazette

25-08
NBB filing Annual accounts filedPDF
financial year 2022 · micro format · 25 days late
2022
31-12
Financial Equity above €200,000equity €238,396 ▲103%
A profit in every financial year since 2021 builds equity to €238,396.
26-07
NBB filing Annual accounts filedPDF
financial year 2021 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

Register details

Who it is

KBO record
Name ANALYTIKK in Dutch
Enterprise number 0755.963.461
Legal form Private limited company
Status Active, normale toestand
Founded 09-10-2020
Type Legal entity

Where it is based

Registered office Blauwe gaanweg 36, 9150 Beveren-Kruibeke-Zwijndrecht, Belgium
Establishments 1 establishment unit since 2020

What it does

NACEBEL 2025
86910 Medical imaging and medical laboratories main activity
21100 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209 Manufacture of basic pharmaceutical products and pharmaceutical preparations
73200 Market research and public opinion polling

Invoicing and payment

VAT number BE 0755.963.461
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0755963461
Also 9925:BE0755963461

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders.

Sites & property

Registered office and establishments
registered office establishment The establishment unit on the map
1 establishment unit
ANALYTIKK
Blauwe gaanweg 36, 9150 Beveren-Kruibeke-ZwijndrechtMedical imaging and medical laboratories
since 2020unit no. 2.308.248.523

Buildings and parcels at the address

Ground area
1,468 m²
Building footprint
181 m²
Building volume
642 m³
Parcel 46001B0818/00M000, Flanders · tallest building 6.0 m.
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
46001B0818/00M000 Flanders 1,468 m² 1 · 181 m² 6.0 m · 2